Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

45 Results

Guidelines and Advice

Radionuclide Therapy for Patients with Neuroendocrine Tumors (NETs) in Ontario: Expert Panel Report

Status: Current
ID: GL-C50-01

Jan 2011

Guidelines and Advice

Preoperative or Postoperative Therapy for the Management of Patients with Stage II or III Rectal Cancer

Status: In-Review
ID: 2-4
Version: 3

Mar 2019

Guidelines and Advice

Recommendations on screening for breast cancer in average-risk women aged 40–74 years

Nov 2011

Guidelines and Advice

ColonCancerCheck Recommendations for Post-Polypectomy Surveillance

Status: Current

Mar 2019

Drug

amsacrine

Other Name(s): AMSA P D® (Erfa)

Quick Link(s):

Sep 2011

Cancer facts

Patient-provider negotiations may result in lack of appropriate colorectal cancer screening follow-up care

Mar 2019

Guidelines and Advice

Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline

Status: In-Review
ID: GL 6-A-2018-1

Mar 2019

Guidelines and Advice

Follow-Up Model of Care for Cancer Survivors: Recommendations for the Delivery of Follow-up Care for Cancer Survivors in Ontario

Status: Current
ID: N/A
Version: N/A

Mar 2019

Guidelines and Advice

Enhancing the Delivery of Take-Home Cancer Drugs in Ontario

Status: Current

Mar 2019

Pages